Post-IPO Equity Health Care Companies

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.

Context Therapeutics is a clinical-stage biopharmaceutical company.

Smart for Life markets and manufactures nutritional foods and supplements for the global nutraceutical marketplace.

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments.

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Optimi Health is a supplier of GMP psychedelic compounds.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

American Healthcare REIT provides and offers financial support and assistance on buildings.

Redx Pharma is a drug discovery and development company.

WELL Health Technologies is the owner and operator of a portfolio of Primary Healthcare facilities.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

CareTrust specializes in leasing and acquisition of properties for healthcare service providers and healthcare businesses.

Assure Neuromonitoring is a medical company providing outsourced intraoperative neurophysiological monitoring and neurology services.

QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Zentek is a nanomaterials technology company that develops graphene-based technologies.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Revitalist uses cutting-edge, evidence-based treatments for mental health, chronic pain, and general wellness.

Emria is a data-backed drug development and care delivery company.